Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies

BACKGROUND: The unprecedented efficacy of chimeric antigen receptor T (CAR-T) cell immunotherapy of CD19(+) B-cell malignancies has opened a new and useful way for the treatment of malignant tumors. Nonetheless, there are still formidable challenges in the field of CAR-T cell therapy, such as the bi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Ying, Zhitao, He, Ting, Wang, Xiaopei, Zheng, Wen, Lin, Ningjing, Tu, Meifeng, Xie, Yan, Ping, Lingyan, Zhang, Chen, Liu, Weiping, Deng, Lijuan, Wu, Meng, Feng, Feier, Leng, Xin, Du, Tingting, Qi, Feifei, Hu, Xuelian, Ding, Yanping, Lu, Xin-an, Song, Yuqin, Zhu, Jun
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7908740/
https://ncbi.nlm.nih.gov/pubmed/33632155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-07934-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados